documents: FDA-2005-N-0464-0237
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2005-N-0464-0237 | FDA | FDA-2005-N-0464 | Ref2_ERG Revisions 1995 DRAFT FINAL REPORT ECONOMIC THRESHOLD AND REGULATORY FLEXIBILITY ASSESSMENT OF PROPOSED CHANGES TO THE CURRENT GOOD MANUFACTURING PRACTICE REGULATIONS FOR MANUFACTURING, PROCESSING, PACKING, OR HOLDING DRUGS (21CFR210&211) re Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs that are Regulated Under | Supporting & Related Material | Background Material | 2016-08-31T04:00:00Z | 2016 | 8 | 2016-08-31T14:37:59Z | 0 | 0 | 09000064821b7bb7 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref